Sign inJoin waitlistJoin the waitlist

Charles Vite

ACVIM · University of Pennsylvania Health System

Credentials: · ·

History

University of Pennsylvania Health System
Present

DVM Purdue University
1987–1990

Research

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
The Lancet · 2017 · 280 citations
Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease
Science Translational Medicine · 2010 · 280 citations
Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease
Science Translational Medicine · 2015 · First of 19 authors · Corresponding · 176 citations

DO
Daniel Ory
14 papers
FP
Forbes Porter
11 papers
Brian Litt
7 papers
Gregory Worrell
7 papers
James Provenzale
5 papers
Jean Schaffer
5 papers
Patricia Dickson
5 papers
Elizabeth Berry-Kravis
4 papers
James Wilson
4 papers
KP
Katherine Ponder
4 papers
Kathryn Davis
4 papers
Raymond Wang
3 papers

Grants

Intracerebroventricular Cyclodextrin and AAV-Mediated Gene Therapy Forglobal CNS Disease Correction in Feline NPC1 Disease
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.6M · University of Florida
2020–2026
Referral Ctr-Animal Models of Human Genetic Disease
NIH Office of the Director · P40
Contact PI · $4.3M · University of Pennsylvania
1985–2023
Combination Therapy, Biomarkers, and Imaging in Canine Krabbe Disease
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.2M · University of Pennsylvania
2016–2022
Neurophysiologically Based Responsive Pharmacotherapy for Epilepsy
National Institute of Neurological Disorders and Stroke · U01
PI · $1.5M · Mayo Clinic Rochester
2011–2017